Related Experiment Video
Updated: Jul 16, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Practical implementation of HPV vaccines in clinical practice.
1Family Practice Residency, University of Toledo College of Medicine, Ohio, USA.
The Journal of Family Practice
|March 21, 2007
Summary
A new vaccine can prevent human papillomavirus (HPV) infection, reducing cervical cancer and genital warts. Family physicians must understand patient attitudes towards HPV vaccination for successful implementation.
Area of Science:
- Immunology
- Public Health
- Gynecology
Background:
- Human papillomavirus (HPV) is a common infection in the United States, affecting approximately 20 million individuals.
- HPV infection is a leading cause of cervical cancer and genital warts.
Purpose of the Study:
- To highlight the availability and benefits of a new HPV vaccine for girls and young women.
- To inform family physicians about the importance of addressing parental and patient knowledge, attitudes, and concerns regarding HPV vaccination.
Main Methods:
- This study is a review of current literature and vaccine guidelines.
- The focus is on the implications for family physicians in clinical practice.
Main Results:
- An effective HPV vaccine is now approved for females aged 9 to 26 years.
- The vaccine is expected to decrease HPV infection spread and the future incidence of cervical cancer and genital warts.
Conclusions:
- Successful implementation of HPV vaccination requires family physicians to understand and address patient and parental perspectives.
- Addressing concerns and improving knowledge about HPV and its vaccine is crucial for public health efforts to reduce HPV-related diseases.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:51Vaccinations
Overview
01:23Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.